A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Clinical trial NCT06023862 · RECRUITING

Trial details

NCT number: NCT06023862
Sponsor: Yonsei University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Endometrial Neoplasms Uterine Cervical Neoplasms Vulvar Cancer Vagina Neoplasm Clear Cell Carcinoma

Start date: 2024-01-22
Primary completion: 2027-08-31
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.